SNX29

Chr 16

sorting nexin 29

Also known as: A-388D4.1, RUNDC2A

Predicted to enable phosphatidylinositol binding activity. [provided by Alliance of Genome Resources, Jul 2025]

ResearchGenerating clinical summary…
0
Active trials
3
Pubs (1 yr)
P/LP submissions
P/LP missense
0.74
LOEUF
DN
Mechanism· predicted
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.74LOEUF
pLI 0.000
Z-score 2.93
OE 0.52 (0.380.74)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
-1.79Z-score
OE missense 1.23 (1.151.31)
609 obs / 496.6 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.52 (0.380.74)
00.351.4
Missense OE?1.23 (1.151.31)
00.61.4
Synonymous OE?1.51
01.21.6
LoF obs/exp: 23 / 44.0Missense obs/exp: 609 / 496.6Syn Z: -5.76

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

SNX29 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →